Loading...

In the news | GenomeWeb

Microsoft, Adaptive Biotechnologies Partner to Study Immune System Genetics 

January 4, 2018

NEW YORK (GenomeWeb) – Adaptive Biotechnologies announced today that it has partnered with Microsoft to map the genetics of the human immune system, with the aim of detecting cancers and other disease in their earliest stages.

In the news | MSPowerUser

Microsoft partners with Adaptive Biotechnologies to decode the human immune system 

January 4, 2018

Microsoft today announced a partnership with Seattle-based Adaptive Biotechnologies to decode human immune system using AI and machine learning with recent breakthroughs in biotechnology. Their goal of the project is to create a universal blood test that reads a person’s…

In the news | BusinessWire

Adaptive Biotechnologies Announces Partnership with Microsoft to Decode the Human Immune System to Improve the Diagnosis of Disease 

January 4, 2018

Adaptive Biotechnologies, a leader in next-generation sequencing of T- and B-cell receptors of the adaptive immune system, announced today their partnership with Microsoft to map the genetics of the human immune system to detect cancers and other diseases in their…

In the news | Puget Sound Business Journal

Microsoft invests in Seattle biotech, partners to map human immune system 

January 4, 2018

Microsoft partners with Seattle biotech Adaptive Biotechnologies to map the human immune system.

In the news | The Seattle Times

Microsoft invests in Adaptive Biotechnologies to develop blood test to detect diseases 

January 4, 2018

Microsoft’s partnership with Seattle-based Adaptive Biotechnologies will focus on mapping and understanding people’s immune-system responses so that illnesses can be found quickly.

Awards | HIV Vaccine Trials Network

Jonathan Carlson receives inaugural Bonnie Mathieson Young Investigator Award 

March 30, 2017

The HIV Vaccine Trials Network honored Jonathan Carlson with an inaugural Bonnie Mathieson Young Investigator Award for his leading role in research that leveraged machine learning and the trials network’s data to show how HIV variants that are pre-adapted to an individual’s immune…

  • Previous
  • 1
  • 2
  • 3
  • Next